Our Products and Resources | Sanofi USA
At Sanofi, we provide a range of healthcare products, including prescription medicines, vaccines, generics, and resources.
Exploring Our Prescription Product Information | Sanofi USA
Explore Sanofi's comprehensive list of prescription product information, tailored to meet diverse healthcare needs.
Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Oct 16, 2024 · Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
Sanofi Vaccines - Prescribing Information | Sanofi USA
At Sanofi, find our vaccines, including influenza, meningitis, pertussis, and more. Get prescribing information and patient resources.
Over-the-Counter (OTC) Products | Sanofi USA
Discover Sanofi's range of consumer OTC products in the US for various health needs. Find brands website information and social media links.
Contact Us - Information and Resources | Sanofi USA
For general information about our products and programs in the U.S., call 1-800-981-2491, fill out the form using the link below or check our Frequently Asked Questions. CONTACT CUSTOMER SERVICE.
Our Company - Sanofi U.S.
Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare.
Diabetes - Sanofi
Our aim is to transform the way diabetes is managed and treated, not just with medicines, but with a holistic approach to managing the condition. We believe diabetes education is critical for individuals living with the condition and for the healthcare professionals who care for …
LANTUS® (insulin glargine injection) for subcutaneous ... - Sanofi
LANTUS is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. (1) Limitations of Use. Not recommended for treating diabetic ketoacidosis. (1) DOSAGE AND ADMINISTRATION.
Sanofi-aventis U.S. Announces Closure of Kansas City …
Kansas City, MO- August 27, 2009 — Sanofi-aventis U.S. today announced that it will close its Kansas City, Mo. manufacturing site, which is expected to occur by mid-2012. The decision to close the site, which mainly makes solid dose forms of oral medications, is based on a North American decline in demand for products manufactured at this site.